Fc gamma receptor glycosylation modulates the binding of IgG glycoforms: a requirement for stable antibody interactions.

PubWeight™: 0.86‹?›

🔗 View Article (PMID 25345863)

Published in J Proteome Res on November 11, 2014

Authors

Jerrard M Hayes1, Asa Frostell, Eoin F J Cosgrave, Weston B Struwe, Oscar Potter, Gavin P Davey, Robert Karlsson, Cecilia Anneren, Pauline M Rudd

Author Affiliations

1: School of Biochemistry & Immunology, Trinity Biomedical Sciences Institute, Trinity College , Pearse St. Dublin 2, Dublin, Ireland.

Articles by these authors

The broadly neutralizing anti-human immunodeficiency virus type 1 antibody 2G12 recognizes a cluster of alpha1-->2 mannose residues on the outer face of gp120. J Virol (2002) 7.82

Antibody domain exchange is an immunological solution to carbohydrate cluster recognition. Science (2003) 6.68

The impact of glycosylation on the biological function and structure of human immunoglobulins. Annu Rev Immunol (2007) 4.96

Biochemistry and molecular biology of gelatinase B or matrix metalloproteinase-9 (MMP-9). Crit Rev Biochem Mol Biol (2002) 3.53

Proposal for a standard system for drawing structural diagrams of N- and O-linked carbohydrates and related compounds. Proteomics (2009) 2.93

Comparison of the methods for profiling glycoprotein glycans--HUPO Human Disease Glycomics/Proteome Initiative multi-institutional study. Glycobiology (2007) 2.71

Genome-wide association study identifies new prostate cancer susceptibility loci. Hum Mol Genet (2011) 2.51

Ovarian cancer is associated with changes in glycosylation in both acute-phase proteins and IgG. Glycobiology (2007) 2.45

Variability, heritability and environmental determinants of human plasma N-glycome. J Proteome Res (2009) 2.39

A systematic approach to protein glycosylation analysis: a path through the maze. Nat Chem Biol (2010) 2.30

Contrasting IgG structures reveal extreme asymmetry and flexibility. J Mol Biol (2002) 2.10

The mannose receptor mediates dengue virus infection of macrophages. PLoS Pathog (2008) 2.09

Evaluation of the serum N-linked glycome for the diagnosis of cancer and chronic inflammation. Proteomics (2008) 1.94

HPLC-based analysis of serum N-glycans on a 96-well plate platform with dedicated database software. Anal Biochem (2007) 1.92

Altered glycosylation pattern allows the distinction between prostate-specific antigen (PSA) from normal and tumor origins. Glycobiology (2003) 1.91

High throughput isolation and glycosylation analysis of IgG-variability and heritability of the IgG glycome in three isolated human populations. Mol Cell Proteomics (2011) 1.70

Secretory IgA N- and O-glycans provide a link between the innate and adaptive immune systems. J Biol Chem (2003) 1.68

Glycans as cancer biomarkers. Biochim Biophys Acta (2011) 1.66

GlycoBase and autoGU: tools for HPLC-based glycan analysis. Bioinformatics (2008) 1.64

Different glycan structures in prostate-specific antigen from prostate cancer sera in relation to seminal plasma PSA. Glycobiology (2005) 1.60

A strategy to reveal potential glycan markers from serum glycoproteins associated with breast cancer progression. Glycobiology (2008) 1.55

Loci associated with N-glycosylation of human immunoglobulin G show pleiotropy with autoimmune diseases and haematological cancers. PLoS Genet (2013) 1.52

Genes contributing to prion pathogenesis. J Gen Virol (2008) 1.51

Structural and quantitative analysis of N-linked glycans by matrix-assisted laser desorption ionization and negative ion nanospray mass spectrometry. Anal Biochem (2008) 1.49

Human serum IgM glycosylation: identification of glycoforms that can bind to mannan-binding lectin. J Biol Chem (2005) 1.47

Detailed structural analysis of N-glycans released from glycoproteins in SDS-PAGE gel bands using HPLC combined with exoglycosidase array digestions. Methods Mol Biol (2006) 1.43

Genomics meets glycomics-the first GWAS study of human N-Glycome identifies HNF1α as a master regulator of plasma protein fucosylation. PLoS Genet (2010) 1.43

Reactivity-based one-pot synthesis of oligomannoses: defining antigens recognized by 2G12, a broadly neutralizing anti-HIV-1 antibody. Angew Chem Int Ed Engl (2004) 1.41

Inhibition of mammalian glycan biosynthesis produces non-self antigens for a broadly neutralising, HIV-1 specific antibody. J Mol Biol (2007) 1.41

Molecular mechanism of lipopeptide presentation by CD1a. Immunity (2005) 1.41

Effects of aging, body mass index, plasma lipid profiles, and smoking on human plasma N-glycans. Glycobiology (2010) 1.37

The hemopexin and O-glycosylated domains tune gelatinase B/MMP-9 bioavailability via inhibition and binding to cargo receptors. J Biol Chem (2006) 1.36

The minimum information required for a glycomics experiment (MIRAGE) project: improving the standards for reporting mass-spectrometry-based glycoanalytic data. Mol Cell Proteomics (2013) 1.34

Novel glycan biomarkers for the detection of lung cancer. J Proteome Res (2011) 1.33

Detailed glycan analysis of serum glycoproteins of patients with congenital disorders of glycosylation indicates the specific defective glycan processing step and provides an insight into pathogenesis. Glycobiology (2003) 1.32

Glycosylation changes on serum glycoproteins in ovarian cancer may contribute to disease pathogenesis. Dis Markers (2008) 1.27

Aberrant IgG galactosylation precedes disease onset, correlates with disease activity, and is prevalent in autoantibodies in rheumatoid arthritis. Arthritis Rheum (2010) 1.25

Ultra performance liquid chromatographic profiling of serum N-glycans for fast and efficient identification of cancer associated alterations in glycosylation. Anal Chem (2010) 1.25

An analytical and structural database provides a strategy for sequencing O-glycans from microgram quantities of glycoproteins. Anal Biochem (2002) 1.25

Mannan binding lectin and its interaction with immunoglobulins in health and in disease. Immunol Lett (2006) 1.21

Separation of 2-aminobenzamide labeled glycans using hydrophilic interaction chromatography columns packed with 1.7 microm sorbent. J Chromatogr B Analyt Technol Biomed Life Sci (2009) 1.20

Altered glycosylation in tumours focused to cancer diagnosis. Dis Markers (2008) 1.20

Core fucosylation and alpha2-3 sialylation in serum N-glycome is significantly increased in prostate cancer comparing to benign prostate hyperplasia. Glycobiology (2010) 1.20

Human follicular lymphoma cells contain oligomannose glycans in the antigen-binding site of the B-cell receptor. J Biol Chem (2006) 1.19

Inhibition of hybrid- and complex-type glycosylation reveals the presence of the GlcNAc transferase I-independent fucosylation pathway. Glycobiology (2006) 1.18

UniCarbKB: putting the pieces together for glycomics research. Proteomics (2011) 1.17

Function and glycosylation of plant-derived antiviral monoclonal antibody. Proc Natl Acad Sci U S A (2003) 1.16

The O-linked glycosylation of secretory/shed MUC1 from an advanced breast cancer patient's serum. Glycobiology (2008) 1.15

The carbohydrate epitope of the neutralizing anti-HIV-1 antibody 2G12. Adv Exp Med Biol (2003) 1.15

Toolboxes for a standardised and systematic study of glycans. BMC Bioinformatics (2014) 1.15

UniCarb-DB: a database resource for glycomic discovery. Bioinformatics (2011) 1.15

MIRAGE: the minimum information required for a glycomics experiment. Glycobiology (2014) 1.14

Screening antibody-antigen interactions in parallel using Biacore A100. Anal Biochem (2006) 1.14

Glycomic and glycoproteomic analysis of serum from patients with stomach cancer reveals potential markers arising from host defense response mechanisms. J Proteome Res (2011) 1.13

Afamin is a novel human vitamin E-binding glycoprotein characterization and in vitro expression. J Proteome Res (2005) 1.13

EUROCarbDB: An open-access platform for glycoinformatics. Glycobiology (2010) 1.13

Glycosylation of serum ribonuclease 1 indicates a major endothelial origin and reveals an increase in core fucosylation in pancreatic cancer. Glycobiology (2007) 1.13

The glycosylation of human serum IgD and IgE and the accessibility of identified oligomannose structures for interaction with mannan-binding lectin. J Immunol (2004) 1.12

Soluble CD36 ectodomain binds negatively charged diacylglycerol ligands and acts as a co-receptor for TLR2. PLoS One (2009) 1.12

Glycosylation of human pancreatic ribonuclease: differences between normal and tumor states. Glycobiology (2002) 1.08

Glycosylation and the complement system. Chem Rev (2002) 1.06

Partial inhibition of complex I activity increases Ca-independent glutamate release rates from depolarized synaptosomes. J Neurochem (2008) 1.04

Galactosemia, a single gene disorder with epigenetic consequences. Pediatr Res (2010) 1.03

Glycosylation of liver acute-phase proteins in pancreatic cancer and chronic pancreatitis. Proteomics Clin Appl (2010) 1.03

Activation state and intracellular trafficking contribute to the repertoire of endogenous glycosphingolipids presented by CD1d [corrected]. Proc Natl Acad Sci U S A (2010) 1.03

Aberrant PSA glycosylation--a sweet predictor of prostate cancer. Nat Rev Urol (2013) 1.03

Complex genetic regulation of protein glycosylation. Mol Biosyst (2009) 1.02

Method for milk oligosaccharide profiling by 2-aminobenzamide labeling and hydrophilic interaction chromatography. Glycobiology (2011) 1.02

Initiation of the alternative pathway of murine complement by immune complexes is dependent on N-glycans in IgG antibodies. Arthritis Rheum (2008) 1.02

Kinetic studies of small molecule interactions with protein kinases using biosensor technology. Anal Biochem (2005) 1.01

Multiplexed analytical glycomics: rapid and confident IgG N-glycan structural elucidation. J Proteome Res (2011) 1.01

Recovery of intact 2-aminobenzamide-labeled O-glycans released from glycoproteins by hydrazinolysis. Anal Biochem (2002) 1.01

O-glycan sialylation and the structure of the stalk-like region of the T cell co-receptor CD8. J Biol Chem (2003) 1.00

Monoamine oxidases: certainties and uncertainties. Curr Med Chem (2004) 0.99

Polymorphisms in B3GAT1, SLC9A9 and MGAT5 are associated with variation within the human plasma N-glycome of 3533 European adults. Hum Mol Genet (2011) 0.99

Glycan structures of ocular surface mucins in man, rabbit and dog display species differences. Glycoconj J (2008) 0.99

"Internal residue loss": rearrangements occurring during the fragmentation of carbohydrates derivatized at the reducing terminus. Anal Chem (2002) 0.98

5-AZA-2'-deoxycytidine induced demethylation influences N-glycosylation of secreted glycoproteins in ovarian cancer. Epigenetics (2011) 0.98

Interaction of mannan binding lectin with alpha2 macroglobulin via exposed oligomannose glycans: a conserved feature of the thiol ester protein family? J Biol Chem (2006) 0.98

Glycan analysis of monoclonal antibodies secreted in deposition disorders indicates that subsets of plasma cells differentially process IgG glycans. Arthritis Rheum (2006) 0.97

Identification of specific glycoforms of major histocompatibility complex class I heavy chains suggests that class I peptide loading is an adaptation of the quality control pathway involving calreticulin and ERp57. J Biol Chem (2002) 0.96

Common aberrations from the normal human plasma N-glycan profile. Glycobiology (2010) 0.96

Identification of N-glycans from Ebola virus glycoproteins by matrix-assisted laser desorption/ionisation time-of-flight and negative ion electrospray tandem mass spectrometry. Rapid Commun Mass Spectrom (2010) 0.95

Major histocompatibility complex class I molecules expressed with monoglucosylated N-linked glycans bind calreticulin independently of their assembly status. J Biol Chem (2004) 0.95

Glycan characterization of PSA 2-DE subforms from serum and seminal plasma. OMICS (2010) 0.95

Differential glycosylation of polymeric and monomeric IgA: a possible role in glomerular inflammation in IgA nephropathy. J Am Soc Nephrol (2006) 0.94

Monitoring endoplasmic reticulum-to-Golgi traffic of a plant calreticulin by protein glycosylation analysis. Biochemistry (2002) 0.93

New data and an old puzzle: the negative association between schizophrenia and rheumatoid arthritis. Int J Epidemiol (2015) 0.93

Monoglucosylated glycans in the secreted human complement component C3: implications for protein biosynthesis and structure. FEBS Lett (2004) 0.93

Identification of N-glycosylation changes in the CSF and serum in patients with schizophrenia. J Proteome Res (2010) 0.92

Glycosylation influences the lectin activities of the macrophage mannose receptor. J Biol Chem (2005) 0.92

Differentiation between isomeric triantennary N-linked glycans by negative ion tandem mass spectrometry and confirmation of glycans containing galactose attached to the bisecting (beta1-4-GlcNAc) residue in N-glycans from IgG. Rapid Commun Mass Spectrom (2008) 0.92

Complex I is rate-limiting for oxygen consumption in the nerve terminal. J Biol Chem (2009) 0.92